Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine

F Russell, Anne Balloch, Mimi Tang, Jonathan Carapetis, Paul Licciardi, J Nelson, A JENNEY, L TIKODUADUA, L WAQATAKIREWA, Jan Pryor, G BYRNES, Yin Cheung, Edward (Kim) MULHOLLAND

    Research output: Contribution to journalArticleResearchpeer-review

    Abstract

    The aim was to identify an appropriate infant pneumococcal vaccination strategy for resource poor countries. Fijian infants received zero, one, two, or three doses of 7-valent pneumococcal conjugate vaccine (PCV) in early infancy. Following three PCV doses, geometric mean concentration (GMC) to all seven serotypes were ?1.0 ?g/mL, and >85% of children achieved antibody levels ?0.35 ?g/mL at 18 weeks. Following two doses, GMC were lower for 6B, 14, and 23F, but higher for 19F compared with three doses. Following a single dose, significant responses were seen for all serotypes post-primary series compared with the unvaccinated. By 12 months, differences between two and three doses persisted for serotype 14 only. Although GMC following three doses are higher than after two doses, the differences were small. A single dose may offer some protection for most serotypes. � 2009 Elsevier Ltd. All rights reserved.
    Original languageEnglish
    Pages (from-to)5685-5691
    Number of pages7
    JournalVaccine
    Volume27
    Issue number41
    Publication statusPublished - 2009

    Fingerprint

    Conjugate Vaccines
    Pneumococcal Vaccines
    immune response
    vaccines
    dosage
    serotypes
    Vaccination
    Serogroup
    Antibodies
    infancy
    dose response
    vaccination
    antibodies

    Cite this

    Russell, F., Balloch, A., Tang, M., Carapetis, J., Licciardi, P., Nelson, J., ... MULHOLLAND, E. K. (2009). Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine. Vaccine, 27(41), 5685-5691.
    Russell, F ; Balloch, Anne ; Tang, Mimi ; Carapetis, Jonathan ; Licciardi, Paul ; Nelson, J ; JENNEY, A ; TIKODUADUA, L ; WAQATAKIREWA, L ; Pryor, Jan ; BYRNES, G ; Cheung, Yin ; MULHOLLAND, Edward (Kim). / Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine. In: Vaccine. 2009 ; Vol. 27, No. 41. pp. 5685-5691.
    @article{3eebf009097f4045824ca0a690ce90f9,
    title = "Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine",
    abstract = "The aim was to identify an appropriate infant pneumococcal vaccination strategy for resource poor countries. Fijian infants received zero, one, two, or three doses of 7-valent pneumococcal conjugate vaccine (PCV) in early infancy. Following three PCV doses, geometric mean concentration (GMC) to all seven serotypes were ?1.0 ?g/mL, and >85{\%} of children achieved antibody levels ?0.35 ?g/mL at 18 weeks. Following two doses, GMC were lower for 6B, 14, and 23F, but higher for 19F compared with three doses. Following a single dose, significant responses were seen for all serotypes post-primary series compared with the unvaccinated. By 12 months, differences between two and three doses persisted for serotype 14 only. Although GMC following three doses are higher than after two doses, the differences were small. A single dose may offer some protection for most serotypes. � 2009 Elsevier Ltd. All rights reserved.",
    keywords = "antibody, diphtheria pertussis tetanus vaccine, Haemophilus influenzae type b vaccine, hepb, Pneumococcus vaccine, unclassified drug, article, clinical trial, concentration (parameters), conjugate, controlled clinical trial, controlled study, diphtheria, drug dose comparison, female, geometric mean concentration, human, human experiment, immunogenicity, infancy, infant, influenza, male, normal human, pneumococcal infection, priority journal, protection, randomized controlled trial, serotype, single drug dose, tetanus, vaccination, Antibodies, Bacterial, Dose-Response Relationship, Drug, Female, Humans, Infant, Male, Pneumococcal Infections, Pneumococcal Vaccines",
    author = "F Russell and Anne Balloch and Mimi Tang and Jonathan Carapetis and Paul Licciardi and J Nelson and A JENNEY and L TIKODUADUA and L WAQATAKIREWA and Jan Pryor and G BYRNES and Yin Cheung and MULHOLLAND, {Edward (Kim)}",
    year = "2009",
    language = "English",
    volume = "27",
    pages = "5685--5691",
    journal = "Vaccine",
    issn = "0264-410X",
    publisher = "Elsevier",
    number = "41",

    }

    Russell, F, Balloch, A, Tang, M, Carapetis, J, Licciardi, P, Nelson, J, JENNEY, A, TIKODUADUA, L, WAQATAKIREWA, L, Pryor, J, BYRNES, G, Cheung, Y & MULHOLLAND, EK 2009, 'Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine', Vaccine, vol. 27, no. 41, pp. 5685-5691.

    Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine. / Russell, F; Balloch, Anne; Tang, Mimi; Carapetis, Jonathan; Licciardi, Paul; Nelson, J; JENNEY, A; TIKODUADUA, L; WAQATAKIREWA, L; Pryor, Jan; BYRNES, G; Cheung, Yin; MULHOLLAND, Edward (Kim).

    In: Vaccine, Vol. 27, No. 41, 2009, p. 5685-5691.

    Research output: Contribution to journalArticleResearchpeer-review

    TY - JOUR

    T1 - Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine

    AU - Russell, F

    AU - Balloch, Anne

    AU - Tang, Mimi

    AU - Carapetis, Jonathan

    AU - Licciardi, Paul

    AU - Nelson, J

    AU - JENNEY, A

    AU - TIKODUADUA, L

    AU - WAQATAKIREWA, L

    AU - Pryor, Jan

    AU - BYRNES, G

    AU - Cheung, Yin

    AU - MULHOLLAND, Edward (Kim)

    PY - 2009

    Y1 - 2009

    N2 - The aim was to identify an appropriate infant pneumococcal vaccination strategy for resource poor countries. Fijian infants received zero, one, two, or three doses of 7-valent pneumococcal conjugate vaccine (PCV) in early infancy. Following three PCV doses, geometric mean concentration (GMC) to all seven serotypes were ?1.0 ?g/mL, and >85% of children achieved antibody levels ?0.35 ?g/mL at 18 weeks. Following two doses, GMC were lower for 6B, 14, and 23F, but higher for 19F compared with three doses. Following a single dose, significant responses were seen for all serotypes post-primary series compared with the unvaccinated. By 12 months, differences between two and three doses persisted for serotype 14 only. Although GMC following three doses are higher than after two doses, the differences were small. A single dose may offer some protection for most serotypes. � 2009 Elsevier Ltd. All rights reserved.

    AB - The aim was to identify an appropriate infant pneumococcal vaccination strategy for resource poor countries. Fijian infants received zero, one, two, or three doses of 7-valent pneumococcal conjugate vaccine (PCV) in early infancy. Following three PCV doses, geometric mean concentration (GMC) to all seven serotypes were ?1.0 ?g/mL, and >85% of children achieved antibody levels ?0.35 ?g/mL at 18 weeks. Following two doses, GMC were lower for 6B, 14, and 23F, but higher for 19F compared with three doses. Following a single dose, significant responses were seen for all serotypes post-primary series compared with the unvaccinated. By 12 months, differences between two and three doses persisted for serotype 14 only. Although GMC following three doses are higher than after two doses, the differences were small. A single dose may offer some protection for most serotypes. � 2009 Elsevier Ltd. All rights reserved.

    KW - antibody

    KW - diphtheria pertussis tetanus vaccine

    KW - Haemophilus influenzae type b vaccine

    KW - hepb

    KW - Pneumococcus vaccine

    KW - unclassified drug

    KW - article

    KW - clinical trial

    KW - concentration (parameters)

    KW - conjugate

    KW - controlled clinical trial

    KW - controlled study

    KW - diphtheria

    KW - drug dose comparison

    KW - female

    KW - geometric mean concentration

    KW - human

    KW - human experiment

    KW - immunogenicity

    KW - infancy

    KW - infant

    KW - influenza

    KW - male

    KW - normal human

    KW - pneumococcal infection

    KW - priority journal

    KW - protection

    KW - randomized controlled trial

    KW - serotype

    KW - single drug dose

    KW - tetanus

    KW - vaccination

    KW - Antibodies, Bacterial

    KW - Dose-Response Relationship, Drug

    KW - Female

    KW - Humans

    KW - Infant

    KW - Male

    KW - Pneumococcal Infections

    KW - Pneumococcal Vaccines

    M3 - Article

    VL - 27

    SP - 5685

    EP - 5691

    JO - Vaccine

    JF - Vaccine

    SN - 0264-410X

    IS - 41

    ER -

    Russell F, Balloch A, Tang M, Carapetis J, Licciardi P, Nelson J et al. Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine. Vaccine. 2009;27(41):5685-5691.